About
Contact & Profiles
A5027172602
Research Areas
- Ferroptosis and cancer prognosis
- Mathematical Biology Tumor Growth
- Renal cell carcinoma treatment
Second Affiliated Hospital of Zhengzhou University
2022
Background. With the highest mortality and metastasis rate, kidney renal clear cell carcinoma (KIRC) is one of most common urological malignant tumors not sensitive to chemotherapy radiotherapy. Immunotherapy, which proves be effective a big progression, such as PD-1/PD-L1 inhibitors, all KIRC patients. To predict prognosis immunotherapy response, novel immune checkpoint gene- (ICG-) related model essential in clinics. Methods. From public database-downloaded dataset, ICG-related for...
10.1155/2022/9010514
article
EN
Disease Markers
2022-12-30
Coming Soon ...